Novo Nordisk establishes new factory in Denmark

Novo Nordisk establishes a new production facility in Odense, Denmark, an investment of 8.5 billion Danish kroner.

By Lotta Naesenius

December 20, 2024 10:58 AM

The new factory, including a warehouse, will cover 40,000 square meters. Construction has already begun, and the facility is expected to be completed in 2027, according to a press release.

– We are proud to build on our legacy in Denmark and look forward to embarking on this journey in Odense, a well-connected city with a dynamic community and skilled workforce, says Henrik Wulff, Executive Vice President for Product Supply, Quality & IT at Novo Nordisk.

The investment is expected to create approximately 400 new jobs.

In addition, Novo Nordisk has received approval for its acquisition of the contract manufacturer Catalent for $11.7 billion. The acquisition means Novo Nordisk will take over Catalent's three pharmaceutical production facilities located in Italy, Belgium, and the USA.

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.